Objective assessment of metabolic monitoring in patients treated with Seroquel® or Seroquel® XR/quetiapine fumarate: use of IMS Disease Analyzer to assess physician behaviour in the UK and Germany

First published 31/01/2013

Last updated 02/07/2024

EU PAS number:

EUPAS3292

Study

Finalised

Documents

Study protocol

Initial protocol

D1443C00128 Seroquel Risk Minimization Retrosp Observ DB Study Protocol

English (1.52 MB - PDF) View document

Study results

D1443C00128 Clinical Study Report

English (1.16 MB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs